Weighted Average Number of Shares Outstanding For Basic and
Diluted Earnings

893,694

893,416

893,976

893,416

For more detail related to the fiscal year 2018 unaudited second quarter
results, please visit our web site at www.bioqual.com.

Statements herein that are not descriptions of historical facts are
forward-looking and subject to risks and uncertainties. Actual results
could differ materially from those currently anticipated due to a number
of factors including risks relating to the ability to continue to extend
current government contracts and obtain new contracts; the Company’s
ability to obtain new government or commercial contracts; continued
demand for the use of animal models in scientific research; the
Company’s ability to perform under its contracts in accordance with the
requirements of the contracts; the actual costs incurred in performing
the Company’s contracts and its ability to manage its costs, including
its capital expenditures; dependence on third parties; future capital
needs; the ability to fund its capital needs through the use of its cash
on hand and line of credit; and the future availability and cost of
financing/capital sources to the Company.